John A Howe - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

John A Howe

Showing results (41-50 of 44) with videos related to

Pageof 5

Sort By:

You have reached the last page of results.This site can display upto 44 results.

ACS Medicinal Chemistry Letters|June 6, 2014

Novel Quinoline-Based P2-P4 Macrocyclic Derivatives As Pan-Genotypic HCV NS3/4a Protease InhibitorsUnmesh Shah, Charles Jayne, Samuel Chackalamannil, et al.

Nature|September 30, 2015

Selective small-molecule inhibition of an RNA structural elementJohn A Howe, Hao Wang, Thierry O Fischmann, et al.

Viruses|July 27, 2024

Novel Pan-Coronavirus 3CL Protease Inhibitor MK-7845: Biological and Pharmacological ProfilingNadine Alvarez, Gregory C Adam, John A Howe, et al.

Journal of Medicinal Chemistry|February 16, 2024

Invention of MK-7845, a SARS-CoV-2 3CL Protease Inhibitor Employing a Novel Difluorinated Glutamine MimicValerie W Shurtleff, Mark E Layton, Craig A Parish, et al.

Pageof 5

Search research articles

Showing results (41-50 of 44) with videos related to

Sort By:

Pageof 5

You have reached the last page of results.This site can display upto 44 results.

ACS Medicinal Chemistry Letters|June 6, 2014

Novel Quinoline-Based P2-P4 Macrocyclic Derivatives As Pan-Genotypic HCV NS3/4a Protease InhibitorsUnmesh Shah, Charles Jayne, Samuel Chackalamannil, et al.

Nature|September 30, 2015

Selective small-molecule inhibition of an RNA structural elementJohn A Howe, Hao Wang, Thierry O Fischmann, et al.

Viruses|July 27, 2024

Novel Pan-Coronavirus 3CL Protease Inhibitor MK-7845: Biological and Pharmacological ProfilingNadine Alvarez, Gregory C Adam, John A Howe, et al.

Journal of Medicinal Chemistry|February 16, 2024

Invention of MK-7845, a SARS-CoV-2 3CL Protease Inhibitor Employing a Novel Difluorinated Glutamine MimicValerie W Shurtleff, Mark E Layton, Craig A Parish, et al.

Pageof 5